Clinical Trial Update: Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a chimeric skin product in patients with epidermolysis bullosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa

Drugs mentioned

• Chimeric Skin

Snippet

Sponsor: Tigenix S.A.U. | Conditions: EPIDERMOLYSIS BULLOSA | Phase 2 | Status: COMPLETED